Table of contents

Original Articles

• Long-term survival after paclitaxel plus platinum-based combination chemotherapy for extraovarian peritoneal serous papillary carcinoma: is it different from that for ovarian serous papillary cancer? (1 March, 2006)

  A. Ayhan, C. Taskiran, N. Yigit-Celik, G. Bozdag, M. Gultekin, A. Usubutun, N. Guler, K. Yuce
• Long-term survival in advanced ovarian carcinoma following cytoreductive surgery with standard peritonectomy procedures (1 March, 2006)

  A.-A. K. Tentes, C. G. Mirelis, S. K. Markakidis, K. A. Bekiaridou, I. G. Bougioukas, A. I. Xanthoulis, E. G. Tsalkidou, G. H. Zafiropoulos, I. H. Nikas
• The utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancer (1 March, 2006)

  T. S. Barlow, M. Przybylski, J. M. Schilder, D. H. Moore, K. Y. Look
• Clinicopathologic study of the putative precursor lesions of epithelial ovarian cancer in low-risk women (1 March, 2006)

  E. C. Tok, D. Ertunc, C. Tataroglu, G. Yazici, H. Kanat, S. Dilek
• Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer (1 March, 2006)

  C. J. Poole, T. Perren, S. Gawande, M. Ridderheim, J. Cook, A. Jenkins, D. Roychowdhury
• Unfavorable prognostic value of CD24 expression in sections from primary and relapsed ovarian cancer tissue (1 March, 2006)

  P. Surowiak, V. Materna, I. Kaplenko, M. SpaczyŃSki, M. Dietel, G. Kristiansen, H. Lage, M. Zabel
• Suppression of human ovarian carcinoma metastasis by the metastasis‐suppressor gene, BRMS1

  (1 March, 2006)

  S. Zhang, Q. D. Lin, W. Di
• Arsenic trioxide–loaded, microemulsion-enhanced cytotoxicity on MDAH 2774 ovarian carcinoma cell line (1 March, 2006)

  M. C. Terek, B. Karabulut, N. Selvi, L. Akman, Y. Karasulu, I. Ozguney, A. U. Sanli, R. Uslu, A. Ozsaran
• Synergistic antitumor effect of tumor necrosis factor–related apoptosis‐inducing ligand combined with cisplatin in ovarian carcinoma cell lines in vitro and in vivo

  (1 March, 2006)

  P. Liu, H. Mao, P. Hou
• Expression of cyclooxygenase-2 and inducible nitric oxide synthase in ovarian surface epithelial carcinomas: is there any correlation with angiogenesis or clinicopathologic parameters? (1 March, 2006)

  E. ÖZel, H. E. PeŞTereli, T. ŞImŞEk, G. ErdoĞAn, F. Ş. Karaveli
• Computerized nuclear morphometry for the prediction of inguinal lymph nodes metastases in squamous cell carcinoma of the vulva (1 March, 2006)

  O. Lavie, I. Maini, A. Pilip, G. Comerci, E. Sabo, P. A. Cross, B. Dawlatly, A. Lopes, R. Auslender
• Gene expression patterns in advanced human cervical cancer (1 March, 2006)

  P. W. Grigsby, M. Watson, M. A. Powell, Z. Zhang, J. S. Rader
• Risk factors of having high-grade cervical intraepithelial neoplasia/invasive carcinoma in women with atypical glandular cells of undetermined significance smears (1 March, 2006)

  S. B. Chichareon, S. Tocharoenvanich
• Angiogenesis in cervical intraepithelial neoplasia and early-staged uterine cervical squamous cell carcinoma: clinical significance (1 March, 2006)

  S. Triratanachat, S. Niruthisard, P. Trivijitsilp, D. Tresukosol, N. Jarurak
• Angiomyofibroblastoma of the vagina in a postmenopausal breast cancer patient treated with tamoxifen: clinicopathologic analysis of a case and review of the literature (1 March, 2006)

  M. Varras, C. Akrivis, A. Demou, E. Kitsiou, N. Antoniou
• Investigation of human papillomavirus by hybrid capture II in cervical carcinomas including 113 adenocarcinomas and related lesions (1 March, 2006)

  M. A.R. Moreira, A. Longato-Filho, E. Taromaru, G. Queiroz, L F JubÉ, S. A. Pinto, F. C. Schmitt
• Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia (1 March, 2006)

  J. Monsonego, J. Pintos, C. Semaille, M. Beumont, R. Dachez, L. Zerat, A. Bianchi, E. Franco
• Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil: implications for health education and prevention (1 March, 2006)

  E. D. Moreira, B. G. Oliveira, F. M. Ferraz, S. Costa, J O Costa Filho, G. Karic
• Correlation of human papillomavirus and adeno-associated virus 2 infection in cytology with Korean women (1 March, 2006)

  J. Hyun-Sun, C. Heung-Jae, K. Byung-Hun, C. Young-Lae, N. Gye-Hyun, C. Ho-Sun, K. Chong-Kook, H. Byoung-Don, B. Su-Mi, A. Woong-Shick
• Correlation between MRI and histopathologic findings in stage I cervical carcinomas: influence of stromal desmoplastic reaction (1 March, 2006)

  K. Itoh, T. Shiozawa, S. Ohira, S. Shiohara, I. Konishi
• Long-term follow-up after large-loop excision of the transformation zone: evaluation of 22 years treatment of high-grade cervical intraepithelial neoplasia (1 March, 2006)

  D Van Hamont, M. A.P.C. Van Ham, P. H.T.H. Struik-Van Der Zanden, K. G.G. Keijser, J. Bulten, W. J.G. Melchers, L. F.A.G. Massuger
• Chronic pelvic pain: a rare complication following a large-loop excision of the transformation zone (1 March, 2006)

  K. Sieunarine, F. Lawton, J. R. Smith
• Significance of tumor volume and corpus uteri invasion in cervical cancer patients treated by radiotherapy (1 March, 2006)

  K. Narayan, R. Fisher, D. Bernshaw
• Neoadjuvant chemotherapy in cervical cancer: a 67 patients experience (1 March, 2006)

  L. Selvaggi, V. Loizzi, A R Di Gilio, C. Nardelli, C. Cantatore, G. Cormio
• Hyperbaric oxygen therapy for delayed radiation injuries in gynecological cancers (1 March, 2006)

  D. Fink, N. Chetty, J. P. Lehm, D. E. Marsden, N. F. Hacker
• Micrometastases detected by cytokeratin 19 expression in sentinel lymph nodes of patients with early-stage cervical cancer (1 March, 2006)

  H. Y. Wang, J. M. Sun, H. F. Lu, D. R. Shi, Z. L. Ou, Y. L. Ren, S. Q. Fu
• Sentinel node identification in cervical cancer patients undergoing transperitoneal radical hysterectomy: a study of 100 cases (1 March, 2006)

  D. Wydra, S. Sawicki, S. Wojtylak, T. Bandurski, J. Emerich
• The risk of residual neoplasia in women with microinvasive squamous cervical carcinoma and positive cone margins (1 March, 2006)

  C. Phongnarisorn, J. Srisomboon, S. Khunamornpong, S. Siriaungkul, P. Suprasert, K. Charoenkwan, C. Cheewakriangkrai, S. Siriaree, T. Pantasri
• Human immunodeficiency virus testing in patients with invasive cervical carcinoma: a prospective trial of the gynecologic oncology group (1 March, 2006)

  A. Calkins, F. B. Stehman, B. Bundy, J. A. Benda, R. S. Mannel, P. Seago, F. Cappuccini, R. D. Alvarez, B. J. Monk, M. Maiman
• Analyses of atypical squamous cells refined by the 2001 Bethesda System: the distribution and clinical significance of follow-up management (1 March, 2006)

  S. J. Lee, K. L. Jung, J. W. Lee, S. Y. Song, B. G. Kim, J. H. Lee, C. S. Park, D. S. Bae
• Radiation-induced benign glandular cells in posthysterectomy smears: a cytomorphologic and clinical analysis (1 March, 2006)

  E. Yavuz, Y. OzlÜK, S. KÜÇÜCÜK, S. Tuzlali, S. E. Akhan, R. Ilhan, S. Topuz, A. İPlikÇI
• Female circumcision (female genital mutilation): a problem for brachytherapy in cervical cancer (1 March, 2006)

  M. F. Manji, I. Al Badawi, A. El Enbaby, N. Al Bareedy
• Acceptability of human immunodeficiency virus testing in patients with invasive cervical cancer in Kenya (1 March, 2006)

  P. Gichangi, B. Estambale, J. Bwayo, K. Rogo, S. Ojwang, E. Njuguna, M. Temmerman
• Multinucleation of koilocytes is actually multilobation (1 March, 2006)

  N. H. Cho, S. Kang, S. Hong, G. B. Jeong, I. W. Choi, H. J. Choi, H. K. Choi
• Analysis of differential protein expression by cisplatin treatment in cervical carcinoma cells (1 March, 2006)

  E. K. Yim, K. H. Lee, C. J. Kim, J. S. Park
• Distinctive cell cycle regulatory protein profiles by adenovirus delivery of p53 in human papillomavirus–associated cancer cells (1 March, 2006)

  H. S. Jin, S. M. Bae, Y. W. Kim, J. M. Lee, S. E. Namkoong, B. D. Han, Y. J. Lee, C. K. Kim, H. J. Chun, W. S. Ahn
• Phenotypic features with p53 alterations related to human papillomavirus and prognostic evaluation in cervical cancer (1 March, 2006)

  X. Lu, A. Feki
• Extended effects of human papillomavirus 16 E6-specific short hairpin RNA on cervical carcinoma cells (1 March, 2006)

  L. Bai, L. Wei, J. Wang, X. Li, P. He
• Differential viral loads of human papillomavirus 16 and 58 infections in the spectrum of cervical carcinogenesis (1 March, 2006)

  H. C. Lai, M. Y. Peng, S. Nieh, C. P. Yu, C. C. Chang, Y. W. Lin, C. A. Sun, T. Y. Chu
• Molecular variants of human papillomavirus type 16 and risk for cervical neoplasia in South Africa (1 March, 2006)

  J. J. Tu, L. Kuhn, L. Denny, K. J. Beattie, A. Lorincz, T. C. Wright
• Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo

  (1 March, 2006)

  X. Y. Niu, Z. L. Peng, W. Q. Duan, H. Wang, P. Wang
• Erythropoietin receptor expression in biopsy specimens from patients with uterine cervix squamous cell carcinoma (1 March, 2006)

  G. Shenouda, A. Mehio, L. Souhami, M. Duclos, L. Portelance, A. Belenkov, T. Chow
• Association between CD31 expression and histopathologic features in stage IB squamous cell carcinoma of the cervix (1 March, 2006)

  A L Silva-Filho, P. Traiman, S. A. Triginelli, F. M. Reis, M. S. Pedrosa, D. Miranda, E. S. Abreu, R. Macarenco, J R Cunha-Melo
• Inactivation of Crk SH3 domain‐binding guanine nucleotide‐releasing factor (C3G) in cervical squamous cell carcinoma

  (1 March, 2006)

  K. Okino, H. Nagai, H. Nakayama, D. Doi, K. Yoneyama, H. Konishi, T. Takeshita
• Increased cyclooxygenase-2 expression is correlated with suppressed antitumor immunity in cervical adenocarcinomas (1 March, 2006)

  T. H. Chen, K. Fukuhara, M. Mandai, N. Matsumura, M. Kariya, K. Takakura, S. Fujii
• Contemporary experience with the management of vulval intraepithelial neoplasia in Northern Ireland (1 March, 2006)

  A. A. Zawislak, J. H. Price, S. P. Dobbs, H. R. Mcclelland, W. G. Mccluggage
• A randomized phase II trial of indole-3-carbinol in the treatment of vulvar intraepithelial neoplasia (1 March, 2006)

  R. Naik, S. Nixon, A. Lopes, K. Godfrey, M. H. Hatem, J. M. Monaghan
• Genital human papillomavirus infection in the male sexual partners of women with isolated vulvar lesions (1 March, 2006)

  M. Z. Taner, C. Taskiran, M. A. Onan, A. Uluturk, O. Himmetoglu
• The role of omentectomy and appendectomy during the surgical staging of clinical stage I endometrial cancer (1 March, 2006)

  S. Dilek, U. Dilek, M. Dede, M. S. Deveci, M. C. Yenen
• Analysis of clinicopathologic factors predicting para-aortic lymph node metastasis in endometrial cancer (1 March, 2006)

  H. Nomura, D. Aoki, N. Suzuki, N. Susumu, A. Suzuki, Y. Tamada, F. Kataoka, A. Higashiguchi, S. Ezawa, S. Nozawa
• Does immediate hormone replacement therapy affect the oncologic outcome in endometrial cancer survivors? (1 March, 2006)

  A. Ayhan, C. Taskiran, S. Simsek, Atike Sever
• The effect of long-term use of progesterone therapy on proliferation and apoptosis in simple endometrial hyperplasia without atypia (1 March, 2006)

  T. Bese, A. Vural, M. Ozturk, F. Dagistanli, F. Demirkiran, M. Tuncdemir, M. Arvas, C. Sanioglu, D. Kosebay
• Uterine effects of tamoxifen: a prospective study (1 March, 2006)

  K. F. Mcgonigle, D. D. Smith, H. F. Marx, R. J. Morgan, S. A. Vasilev, S. Roy, P. T. Wong, J. F. Simpson, S. P. Wilczynski
• Neuroendocrine features in poorly differentiated endometrioid adenocarcinomas of the endometrium (1 March, 2006)

  T. Tamura, T. Jobo, J. Watanabe, T. Kanai, H. Kuramoto
• Expression of estrogen receptor–related receptor isoforms and clinical significance in endometrial adenocarcinoma (1 March, 2006)

  M. Gao, P. Sun, J. Wang, D. Zhao, L. Wei
• Genome-wide analysis of deoxyribonucleic acid in endometrial cancer using comparative genomic hybridization microarrays (1 March, 2006)

  S A O'toole, E. Dunn, B. L. Sheppard, H. Klocker, J. Bektic, P. Smyth, C. Martin, O. Sheils, J J O'leary
• Euonymus alatus (Thunb.) Sieb induces apoptosis via mitochondrial pathway as prooxidant in human uterine leiomyomal smooth muscle cells

  (1 March, 2006)

  C.-H. Kim, D.-I. Kim, C.-N. Kwon, S.-K. Kang, U.-H. Jin, S.-J. Suh, T.-K. Lee, I.-S. Lee
• p53, epidermal growth factor, and platelet-derived growth factor in uterine leiomyosarcoma and leiomyomas (1 March, 2006)

  S. E. Anderson, D. Nonaka, S. Chuai, A. B. Olshen, D. Chi, P. Sabbatini, R. A. Soslow
• Whole-body positron emission tomography with F-18 fluorodeoxyglucose for the detection of recurrence in uterine sarcomas (1 March, 2006)

  M. Murakami, H. Tsukada, M. Shida, M. Watanabe, H. Maeda, S. Koido, T. Hirasawa, T. Muramatsu, T. Miyamoto, S. Nasu, S. Yasuda, H. Kajiwara, M. Yasuda, M. Ide
• Uterine sarcomas in breast cancer patients treated with tamoxifen (1 March, 2006)

  M. Arenas, A. Rovirosa, V. HernÁNdez, J. Ordi, S. Jorcano, B. Mellado, A. Biete
• Evolution of treatment of high-risk metastatic gestational trophoblastic tumors: Ain Shams University experience (1 March, 2006)

  I.K.I El-Lamie, H. M. El Sayed, A. G. Badawie, W. A. Bayomi, H. A. El-Ghazaly, A. E. Khalaf-Allah, M. N. El-Mahallawy, K. I. El-Lamie
• Gestational trophoblastic tumor in pregnancy: a case report and review of the literature (1 March, 2006)

  A. V. Dy Echo, A. S. Soriano-Estrella
• The role of hysterotomy in the management of gestational trophoblastic neoplasia (1 March, 2006)

  W. A.A. Tjalma, J. B. Vermorken